Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

3D-printable and degradable scaffolds for adipose tissue regeneration

Reference number
Coordinator Akira Science AB
Funding from Vinnova SEK 300 000
Project duration November 2022 - June 2023
Status Completed
Venture Innovative Startups
Call Innovative Impact Startups autumn 2022

Important results from the project

The aim of the project was partially fulfilled through the identification of new variables that could impact the workflow. Despite the encountered limitations, we successfully produced prototypes which were used to showcase the outstanding material properties. Our team optimized protocols for filament production and implant printing, implementing a meticulously detailed workflow. Consequently, we successfully produced and sterilized degradable implants that will be utilized in a preclinical study.

Expected long term effects

We have successfully synthesized three material batches by fine-tuning a newly identified variable. While we were unable to scale up the synthesis to the desired quantity, we have effectively confirmed that each batch satisfies the application requirements. However, the larger synthesis was impeded by the increased cost of the feedstock ingredients. Furthermore, the achieved results have facilitated the establishment of a partnership with a renowned biomedical research institute, enabling us to conduct further validation of our implants in an upcoming preclinical study.

Approach and implementation

The project plan was divided into three work packages: scale-up material synthesis, optimization of implant production, and sterilization strategy. The first phase concluded within one month as we determined that a large-scale synthesis was not economically viable. Consequently, the second phase commenced earlier, aiming to optimize three material grades, a goal that was successfully achieved within a two-month timeframe. The final phase of the project concluded in two months, aided by the involvement of an external supplier who supported the sterilization process.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 23 June 2023

Reference number 2022-02042